Literature DB >> 8005043

Metastatic myxopapillary ependymoma: report of a case with fine-needle aspiration findings.

R H Bardales1, M C Porter, J R Sawyer, R E Mrak, M W Stanley.   

Abstract

A case of recurrent and metastasizing myxopapillary ependymoma of the sacral region in a 35-yr-old man is reported. Fifteen years after the original diagnosis, he presented with an abdominal mass, subcutaneous nodules in the previous surgical excision line, and bilateral inguinal lymph node enlargement. FNA cytology of the inguinal lymph nodes showed a poorly cohesive, highly cellular smear pattern exhibiting papillary formations and rosette-like structures composed of slim columnar cells having cytoplasmic processes without evidence of atypia. Histologic and ultrastructural findings confirmed the diagnosis. Chromosomal analysis was also done.

Entities:  

Mesh:

Year:  1994        PMID: 8005043     DOI: 10.1002/dc.2840100113

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  4 in total

1.  Long term outcomes following surgical resection of myxopapillary ependymomas.

Authors:  Carlos A Bagley; Sean Wilson; Karl F Kothbauer; Markus J Bookland; Fred Epstein; George I Jallo
Journal:  Neurosurg Rev       Date:  2009-02-17       Impact factor: 3.042

2.  Myxopapillary ependymoma: Lesser known cytomorphologic features.

Authors:  Monisha Choudhury; Archna Rautela; Manupriya Nain
Journal:  J Cytol       Date:  2015 Jan-Mar       Impact factor: 1.000

3.  An Extremely Rare Case of Back and Hip Pain due to the Metastasis of Late Recurrent Myxopapillary Ependymoma to the Inguinal Lymph Node.

Authors:  Suheyla Ekemen; Ozlem Yapicier; Hatice Deniz Boler; Umit Ince
Journal:  J Pathol Transl Med       Date:  2017-11-23

4.  Extraneural metastasis of ependymoma in the cauda equina.

Authors:  Takahito Fujimori; Motoki Iwasaki; Yukitaka Nagamoto; Masafumi Kashii; Hironobu Sakaura; Hideki Yoshikawa
Journal:  Global Spine J       Date:  2012-11-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.